Home Data Technology
Crowd Platform
Data Transaction
Medical Devices
Technology About Us Contact & Partnership
中文 EN 日本語

Medical Ozone Therapy Device

An innovative therapy for tubal obstructive infertility — guided by the principle of bio-oxidation restoring natural conception, delivering the strong oxidising and debriding action of ozone precisely where it is needed.

National Class II medical device registration Ozone concentration 15–65 mg/L Error ≤ ±5% Consumable loop
Principle

Bio-oxidation · restoring natural conception

A single treatment proceeds through three progressive stages: recanalise, repair, then protect.

01

Precise recanalisation

Using the strong oxidising and debriding action of ozone to treat the obstructed fallopian tube site in a targeted way, improving luminal patency.

02

Functional restoration

Promoting repair of the tubal mucosa and ciliated epithelium, helping restore ovum capture and transport and creating the conditions for natural conception.

03

Outcome protection

By lavaging the pelvic cavity and suppressing local infection and inflammation, reducing the risk of post-operative re-adhesion.

Clinical Data

Let efficacyspeak through data

92.78%
Tubal recanalisation rate
Observational statistics from partner hospitals
48.15%
Natural pregnancy rate within one year
Post-operative follow-up statistics
20%
Post-operative re-adhesion rate
Outcomes of the integrated anti-inflammatory and anti-adhesion design

* The observational data comes from statistics compiled at the company's partner hospitals. It is affected by patient population, operator technique and follow-up conditions, and individual results vary. It does not constitute a claim of efficacy or diagnostic advice.

Core Technology

Two key designs define the ceiling of treatment

Precise ozone concentration control

Ozone concentration is continuously adjustable from 15 to 65 mg/L with an error of ≤ ±5%, real-time monitoring and automatic calibration, keeping every treatment within the set range and avoiding the efficacy variability and safety risks caused by concentration drift.

15-65mg/L
Continuously adjustable concentration
≤±5%
Concentration control error

Combined ozone–microwire intervention

A proprietary microwire-through technique combined with ozone intervention: the microwire first establishes access and a positional reference, then ozone gas or liquid is delivered at the target site, achieving precise recanalisation together with anti-inflammatory and anti-adhesion effects while reducing tissue damage from repeated manipulation.

Dual-phase delivery
gas and liquid forms
Integrated
recanalisation + anti-inflammation + anti-adhesion
Specification

Core specifications

The following are the company's published technical specifications. The actual configuration and indications are governed by the medical device registration certificate and the product instructions.

Ozone concentration
15–65 mg/L, continuously adjustable
Concentration error
≤ ±5%
Oxygen flow
0 – 3 L/min
Ozonated water concentration
≥ 5 mg/L
Safe concentration range
20 – 80 μg/ml
Commonly used clinical concentration
30 – 40 μg/ml
Consumables
Single-use fallopian tube contrast catheter
Control method
Dedicated system control software (copyright registered)

Compliance & traceability

National Class II medical device registration has been obtained and the supporting distribution filing is complete. Indications and contraindications are governed by the registration certificate and the instructions.

Medical Ozone Therapy Device System Control Software V1.0 · 2026SR0627822

Treatment process captured as data

Key parameters such as concentration, flow and delivery duration can be recorded in structured form, helping institutions build standardised treatment templates and efficacy follow-up.

Consumable loop

The innovative fallopian tube contrast catheter supports dual-phase ozone gas and liquid delivery and is used with the main unit, ensuring standardised and consistent operation.

Request detailed materials See the other product, S2
Application

Who uses it, and where

Gynaecology departments in general hospitals

Diagnosis and treatment of tubal obstructive infertility, with referral coordination with fertility centres.

Maternal and child health hospitals

Screening and intervention for tubal factors in healthy-birth clinics.

Fertility clinics

As a pre-treatment step for assisted reproduction, improving the conditions for natural conception.

Regional distributors

Product promotion, installation training and consumable supply for healthcare institutions in the region.

Want to know more about this device?

Tell us your institution type and requirements and we can provide the product instructions, technical parameters, clinical protocol and installation training documentation.